John H. Abeles, Director at Medite Cancer Diagnostics, Inc. (MDIT), bought 306,667 shares at $0.08 ($21K) on 2018-10-11, disclosed to the SEC on 2018-10-23.
Open-market purchase of $21k MDIT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 40,000 | $0 | 0.0% |
| 2 | $0.08 | 266,667 | $21K | 100.0% |
| Total | $0.07 avg | 306,667 | $21K | 100% |
| Filing → |
| DUSA | BUY | 2007-11-14 | $10K | — | Filing → |
| IFLO | SELL | 2007-08-14 | $49K | — | Filing → |
| IFLO | SELL | 2007-08-09 | $286K | — | Filing → |